Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Evolus
< Previous
1
2
3
4
Next >
Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
February 27, 2025
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
February 20, 2025
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025
February 18, 2025
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
February 13, 2025
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company’s Guidance
January 21, 2025
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 13, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Third Quarter 2024 Results
November 06, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Participate in Stifel 2024 Healthcare Conference
November 01, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation
October 31, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Report Third Quarter Financial Results on November 6, 2024
October 23, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 11, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 27, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
September 06, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance
July 31, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Hold Investor Day on September 12, 2024
July 31, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Report Second Quarter Financial Results on July 31, 2024
July 17, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Announces Appointment of Albert G. White III to Board of Directors
July 01, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products
June 24, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain
June 12, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting
May 20, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit
May 15, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Reports First Quarter 2024 Results and Provides Business Update
May 07, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus to Report First Quarter Financial Results on May 7, 2024
April 23, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
April 17, 2024
From
Evolus
Via
Business Wire
Tickers
EOLS
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit